Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2024 Nov;26(11):2758-2770.
doi: 10.1007/s12094-024-03531-3. Epub 2024 Jul 15.

SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023)

Jose Alejandro Perez-Fidalgo  1 , Fernando Gálvez-Montosa  2 , Eva María Guerra  3 , Ainhoa Madariaga  4 , Aranzazu Manzano  5 , Cristina Martin-Lorente  6 , Maria Jesús Rubio-Pérez  7 , Jesus Alarcón  8 , María Pilar Barretina-Ginesta  9 , Lydia Gaba  10
Affiliations
Practice Guideline

SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023)

Jose Alejandro Perez-Fidalgo et al. Clin Transl Oncol. 2024 Nov.

Abstract

In recent years, the incorporation of new strategies to the therapeutic armamentarium has completely changed the outcomes of epithelial ovarian cancer (EOC). The identification of new predictive and prognostic biomarkers has also enabled the selection of those patients more likely to respond to targeted agents. Nevertheless, EOC is still a highly lethal disease and resistance to many of these new agents is common. The objective of this guideline is to summarize the most relevant strategies to manage EOC, to help the clinician throughout the challenging diagnostic and therapeutic processes and to provide evidence-based recommendations.

Keywords: Diagnosis; Guideline; Ovarian cancer; Treatment.

PubMed Disclaimer

Conflict of interest statement

JAPF Reports Advisory Board, Speaker, Grant Non-financial Support from Astrazeneca and GSK; Advisory Board and Speaker from MSD and Clovis; Advisory Board, Speaker and Grant from Pharmamar; Advisory Board from Pharmand and Ability pharma. LGG reports Advisory Board—Speaker—Other from GSK, MSD and AstraZeneca; Speaker from Eisai and Advisory Board—Speaker from Clovis Oncology and PharmaMar. AMU reports Advisory Board—Speaker from Astrazeneca and GSK; Speaker from MSD and Clovis and Advisory Board from PharmaMar. FGM reports Advisory Board—Speaker—Non-financial Support from GSK, AstraZeneca, Clovis and PharmaMar; Advisory Board—Speaker from Roche, GSK, AstraZeneca and MSD and Advisory Board—Speaker—Grant from PharmaMar. JAC reports Advisory Board—Speaker—Grant from GSK; Speaker from Roche and Clovis; Advisory Board—Speaker from Astra Zenenca; Speaker—Grant from MSD and Grant from Pharmamar. EGA reports Advisory Board—Speaker from AstraZeneca-MSD, GSK, Pharmamar, Roche and Clovis and Other from GSK. MPBG reports Advisory Board—Speaker—Other from AatraZeneca, GSK, MSD and Roche; Advisory Board from EISAI and Advisory Board—Speaker from AstraZeneca, Clovis, GSK, MSD and Pharmamar. AMF reports Speaker from MSD, Sanofi, Leo Pharma, Health in Code and Roche; Speaker—Grant from AstraZeneca and Advisory Board—Speaker from GSK. CML, MJRP nothing to disclose.

Figures

Fig. 1
Fig. 1
Management of early and advanced stage EOC
See this image and copyright information in PMC

References

    1. González-Martín A, Harter P, Leary A, Lorusso D, Miller RE, Pothuri B, et al. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(10):833–48. - PubMed
    1. Sociedad Española de Oncología Médica (SEOM). Las cifras del cáncer en España 2023. Depósito Legal: M-3407-2023 ISBN: 978-84-09-48173-6 © 2023.
    1. Wentzensen N, Poole EM, Trabert B, White E, Arslan AA, Patel AV, et al. Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium. J Clin Oncol. 2016;34(24):2888–98. - PMC - PubMed
    1. Konstantinopoulos PA, Norquist B, Lacchetti C, Armstrong D, Grisham RN, Goodfellow PJ, et al. Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline. J Clin Oncol. 2020;38(11):1222–45. - PMC - PubMed
    1. Henderson JT, Webber EM, Sawaya GF. Screening for ovarian cancer: updated evidence report and systematic review for the US preventive services task force. JAMA. 2018;319(6):595–606. - PubMed

Publication types

LinkOut - more resources